远大医药集团有限公司（股票代码：00512）于2026年4月2日披露3月股份变动月报表，报告期为2026年3月。根据公告披露，本月公司注册股本维持为100,000,000,000股，面值每股0.01港元，总额为1,000,000,000港元，未出现任何增加或减少。
报告期末已发行股份数量为3,549,571,148股，与上月持平。无新增股份发行、购回或注销，也未出现库藏股变动。公告同时显示，公司符合香港联交所对于公众持股量的相关要求。关于公司期权及激励计划，公告未披露任何新增或变动信息。
董事会确认本月并无涉及购回股份或其他可能影响已发行股本的事项。该份公告由公司秘书傅天忠签署。公司强调，所有业务及法定合规工作均依照香港联交所《上市规则》及相关法律法规进行。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.